Proving brand value. Maximizing patient access.
Distinguish and deliver your brand’s total value proposition around the globe.
We are Cencora. Our shared identity unites us.
Cencora brings the companies and services of AmerisourceBergen together under one new name.
Keep up on key global health technology assessment news
Latest edition: Fall 2023
With just 17 months until Joint Clinical Assessment (JCA) is implemented for oncology drugs and advanced therapy medicinal products (ATMPs) in the European Union, in this edition we consider what we know so far and what is still uncertain. The authors also reflect on the industry’s perception of the current UK Voluntary Pricing and Access Scheme and hopes for the new scheme scheduled to start in January 2024. Against the backdrop of increased payer interest in and use of US value assessment tools, we question whether ICER’s assessment framework is sufficiently rigorous to accurately capture the value of potentially transformational therapies.
Do more than demonstrate value. Drive it.
Benefit from our global reach:
Proven, value-driven solutions for manufacturers, providers, payers and patients
Global reach. Local expertise.
Manufacturer Commercialization Solutions
From clinical trial to market availability, AmerisourceBergen has solutions for your products' needs today. And, for where your product needs to go tomorrow.
A career that redefines value.
Work on projects that help patients around the world. Work with brilliant minds and people who inspire. Work in a culture that recognizes your commitment and contributions. And find a career that actually works for you.
Whether you work remotely or join us in one of our core locations in Tampa, Charlotte, San Francisco, Washington D.C., or Hannover, Germany, you’ll be part of a culture that recognizes creative thinking, practices giving back to our communities, and encourages entrepreneurship with enriching rewards.